Free Trial

CannaPharmaRX Q4 2022 Earnings Report

CannaPharmaRX logo
$0.0074 0.00 (-2.63%)
As of 01:20 PM Eastern

CannaPharmaRX EPS Results

Actual EPS
-$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

CannaPharmaRX Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

CannaPharmaRX Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

CannaPharmaRX Earnings Headlines

PSIQ Profile Solutions, Inc.
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
CannaPharmaRX, Inc. (CPMD)
CannaPharmaRx to Host Investor Conference Call
See More CannaPharmaRX Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CannaPharmaRX? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CannaPharmaRX and other key companies, straight to your email.

About CannaPharmaRX

CannaPharmaRX (OTCMKTS:CPMD) operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.

View CannaPharmaRX Profile

More Earnings Resources from MarketBeat